Clinical efficacy and prognosis analysis of treatment regimens for EGFR mutant non-small cell lung cancer and brain metastasis: a retrospective study

Clinical efficacy and prognosis analysis of treatment regimens for EGFR mutant non-small cell lung cancer and brain metastasis: a retrospective study

Abstract Background The aims of the study were to evaluate potential differences among first-line treatment for EGFR mutant (m+) non-small cell lung cancer (NSCLC) patients with brain metastasis in China and to identify the factors influencing survival outcomes. Methods In this retrospective study,...

Full description

Bibliographic Details
Main Authors: Huijuan Wang, Ruyue Xing, Mengmeng Li, Mina Zhang, Chunhua Wei, Guowei Zhang, Yuanyuan Niu, Zhiyong Ma, Xiangtao Yan
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Cancer
Subjects:
NSCLC
Tyrosine kinase inhibitors
Bevacizumab
Brain metastasis
Intracranial metastasis
Online Access:https://doi.org/10.1186/s12885-023-10744-2

Internet

https://doi.org/10.1186/s12885-023-10744-2

Similar Items